The prevalence of severe obesity was 9.4%; in each age group, prevalence was higher for women than men. HealthDay News — The prevalence of obesity among adults was 40.3% during August 2021 to August ...
New WHO guidance calls for a worldwide obesity treatment “ecosystem” to ensure that GLP-1 weight-loss drugs are used fairly ...
Bowl of Quick Cook on MSN
A Turning Point in Public Health: Obesity Rates Decline as GLP-1 Drugs Reshape the Fight Against a Decades-Long Crisis
For many years, the narrative surrounding obesity in the United States has been one of relentless increase. From the ...
Obesity has reached crisis levels, and the reasons for its alarming rise are as complex as the disease itself. The causes range from genes and diet to lack of education and access to healthy foods, ...
MedPage Today on MSN
New Guidelines on GLP-1 Drugs for Obesity Released
The recommended use of GLP-1 therapies, including tirzepatide (Zepbound), semaglutide (Wegovy), and liraglutide (Saxenda), ...
Editor’s note: Watch “Dr. Sanjay Gupta Reports: Is Ozempic Right For You?” at 8 p.m. Sunday, November 17, on CNN. In a little over two decades, almost 260 million people in the United States are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback